Dr. Alexis Feuer
Dr. Alexis Jamie Feuer is board certified in Pediatrics and Pediatric Endocrinology and brings over 15 years of experience caring for children. Her main goal is to develop an open, trusting and collaborative relationship with her patients and their families that will last for many years to come. Dr. Feuer completed her Residency in Pediatrics and Pediatric Endocrinology Fellowship at Weill Cornell Medical Center/New York-Presbyterian Hospital in New York. She then served as an Assistant Professor of Pediatrics at Weill Cornell Medicine and Assistant Attending Pediatrician at the NewYork-Presbyterian Phyllis and David Komansky Children's Hospital. While at Cornell, Dr Feuer was named the Caryl & Israel A. Englander Clinical Scholar in Childrenβs Health for her research in growth and bone metabolism.
Dr. Feuer combines compassion with evidence-based medicine to provide the best care possible for her patients.
Academic Background
Medical School University at Buffalo (Jacobs) School of Medicine
Undergraduate and graduate degrees from NYU (BA, MS)
Board Certifications
Dr. Feuer is board certified in:
Pediatrics
Pediatric Endocrinology
Diabetes
Metabolism
Professional Memberships
Endocrine Society
Pediatric Endocrine Society
T1D Exchange
Hospital Privileges
Cooperman Barnabas Medical Center, Livingston, NJ
Get to Know Dr. Alexis Feuer
Why Did You Become a Doctor on Pediatric Endocrinology?
When I was 11 years old, I was diagnosed with Type 1 diabetes. My whole life instantly changed. I was suddenly forced into a new and frightening world of insulin injections, painful blood sugar testing, dietary restrictions and frequent doctor appointments. While I was understandably unhappy about my diagnosis, I was also extremely fascinated by the science behind it. I would read for hours trying to understand the complex processes that were occurring within my body. My endocrinologist was a wonderful person and an amazing resource for me and my family. He helped educate and empower me to care for my diabetes and supported my desire to learn more about medicine. I was 14 years old when I decided I wanted to become a pediatric endocrinologist and help children with chronic and complex medical conditions. As I advanced in my training, I knew that I had made a wonderful choice. Endocrinology, as a practice, is both complex and exciting with incredible new advances and innovations often occurring. However, the biggest reward of becoming a pediatric endocrinologist has been the lasting relationships built with the children and families I treat.
What Is Your Approach to Medicine?
My approach to patient care is built upon a foundation of expertise in the field of pediatric endocrinology coupled with the life experience of being a pediatric patient with a chronic health condition. I believe in order to take the best care of patients and families, you need to be able to take the time to truly listen to their concerns and work collaboratively to develop a diagnosis and treatment plan. My goal is always to alleviate any anxiety or fear a child may have about going to see the doctor and to make the experience relaxed and comfortable.. I want to be able to educate and empower young people and families to understand their diagnoses and the available resources and treatment options. Building trust and successful relationships takes time. At many practices, you are given less than 15 minutes to see patients!
That is why I am so thrilled to be a part of the Well by Messer team, who I know shares my passion for evidence-based patient-centered care.
How Would You Define Patient Care?
Patient care is the combination of providing expertise coupled with empathy, understanding and respect. It is treating your patients as if they were your own children. It is taking the time to listen and support children and families when they are at their most vulnerable. It is about empowering through education and kindness.
Do You Do Any Philanthropic Work?
I am involved with JDRF and community organizations in New Jersey where we live. I also volunteer at my sonβs preschool as often as I can (the kids are so cute!)
Publications
Ebekozien O, Agarwal S, Noor N, Albanese-O'Neill A, Wong JC, Seeherunvong T, Sanchez J, DeSalvo D, Lyons SK, Majidi S, Wood JR, Acharya R, Aleppo G, Sumpter KM, Cymbaluk A, Shah NA, Van, Name M, Cruz-Aviles L, Alonso GT, Gallagher MP, Sanda S, Feuer AJ, Cossen K, Rioles N, Jones, NY, Kamboj MK, Hirsch IB. Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers. J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1755-e1762
Feuer AJ, Thai A, Demmer RT, Vogiatzi M. Association of Stimulant Medication Use with Bone Mass in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. JAMA Pediatr. 2016; e162804
Feuer AJ, Thai A. Stimulant Use and Bone Mineral Density-Reply. JAMA Pediatr. 2017 May 1;171(5):495
Feuer AJ, Demmer RT, Thai A, Vogiatzi MG. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study. Bone. 2015; 78:28-33
Feuer AJ, Censani M. A 5-Year-Old Female With Short Stature. Clin Pediatr (Phila). 2015
Censani M, Feuer A, Orton S, Askin G, Vogiatzi M. Changes in body mass index in children on gonadotropin-releasing hormone agonist therapy with precocious puberty, early puberty or short stature. J Pediatr Endocrinol Metab. 2019
Medical Talks & Presentations
Weill Cornell Endocrinology Grand Rounds (June 2016, September 2021)
Inhaled Beta-Agonists and Bone Mass in Children and Adolescents. Pediatric Endocrine Society Meeting; Washington D.C., September 2017
Use of Stimulant Medications and Bone Health in Children. Endocrine Society Meeting, Boston, MA, April 2016
Selective Serotonin Reuptake Inhibitors Decrease Bone Mass in Pediatrics. Pediatric Endocrine Society Meeting, Vancouver September 2014
Selective Serotonin Reuptake Inhibitors Decrease Bone Mass in Pediatrics. Endocrine Society Meeting, Chicago April 2014
QI Project: Bullying. Association of Pediatric Program Directors Meeting, Nashville 2013
Screening for Psychosocial Impairment in Adolescent Patients. Pediatric Academic Society, Washington D.C. 2012
Research Grants, Awards & Recognitions
Caryl & Israel A. Englander Clinical Scholar Award in Childrenβs Health: Weill Cornell Medicine, June 2017-2020
New York Times Super Doctors - Rising Star, 2017-2020
Pediatric Endocrine Society Drugs and Therapeutics Committee, July 2014- June 2016
Outstanding Abstract Award, Endocrine Society 2016 Meeting
Endocrine Society Type 1 Diabetes Care and Management Fellows Conference Grant, June 2014
Pediatric Endocrine Society Spring Retreat Grant, May 2014
Emilie Davis Rodenberg Memorial Award for Excellence in the Study of Diabetes, University at Buffalo School of Medicine, June 2009
Medical Specialties
Growth Disorders (Growth Hormone Deficiency, Idiopathic Short Stature)
Pubertal Disorders (Precocious/Early puberty, Pubertal Delay)
Pediatric and Adolescent Weight management
Amenorrhea/oligomenorrhea (absent or infrequent menstrual periods)
Congenital Adrenal Hyperplasia
Cushingβs disease (elevated cortisol levels)
Gynecomastia (breast formation in males)
Metabolic Bone disease
Fractures
Hypercalcemia/hypocalcemia (high and low calcium levels)
Hyperlipidemia (high cholesterol levels)
Hyperparathyroidism (high parathyroid hormone levels)
Hypoglycemia (low blood glucose levels)
Thyroid nodules
Hyperthyroidism
Hypothyroidism
Type 1 diabetes
Type 2 diabetes
Pituitary adenomas (pituitary masses)
Polycystic ovarian syndrome
Prolactinomas (elevated levels of the hormone that produces breast milk)
Gender dysphoria and Gender-affirming hormone treatment